DiGiSPICE Technologies Regulatory Approval

Board Meeting Date

DiGiSPICE Technologies Board Meeting Date

DiGiSPICE Technologies' board met on 3 Nov 2026 to approve Q2/H1 FY27 un-audited results. No financial figures or material decisions yet reported.

Other Announcement

DiGiSPICE Technologies Other Announcement

Digispice Technologies Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI listing regulations.

Annual General Meeting

DiGiSPICE Technologies Annual General Meeting

DiGiSPICE filed proceedings of its 38th AGM held 22 Sept 2026, covering adoption of FY26 financials, director re-appointment and an ex-gratia resolution. No voting results or dividend were disclosed in this filing.

Employee Stock Options

DiGiSPICE Technologies Employee Stock Options

DiGiSPICE Technologies has approved the grant of 400,000 stock options to eligible employees under its existing 2018 employee stock option plan.

Other Announcement

DiGiSPICE Technologies Other Announcement

DiGiSPICE Technologies Limited has issued a letter to shareholders regarding the 38th AGM and Annual Report 2025-26. Shareholders are advised on e-voting procedures and KYC updates.

Annual General Meeting

DiGiSPICE Technologies Annual General Meeting

DiGiSPICE Technologies Limited has scheduled its 38th Annual General Meeting for September 22, 2026. The company also released its Annual Report for the financial year 2025-26.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.